All updated as on -
From 2024–2031, experts predict that the vitamin K2 market size will increase from 85.14 billion USD in 2023 to 3.19 billion USD in 2031, a CAGR (compound annual growth rate) of 6.5%. The market was valued at 111.99 billion USD in 2024. Increases in the worldwide elderly population, the prevalence of cardiovascular disease and osteoporosis, and the need for nutritious foods and supplements are all factors that will propel the vitamin K2 market to new heights.
Blood clotting, heart health, and bone density are among areas that vitamin K2 can influence. Among them, MK-4 and MK-7 stand out. A reduced risk of heart disease is closely linked to a higher intake of vitamin K2. In addition to preventing heart disease and promoting healthy brain function, it also aids in skin health and bone metabolism. Vitamin K2 also aids in calcium use, which is critical for bone growth and vascular calcification prevention. By activating the matrix GLA protein (MGP), vitamin K2 inhibits the calcification of blood arteries, protecting them from harm.
Since un-carboxylated or inactive MGP causes cardiovascular disease, vitamin K2 deficiency is a direct cause of this condition. Vitamin K2 also helps the blood clot. To avoid internal and external bleeding, vitamin K2 is necessary for the synthesis of several proteins that are involved in blood clotting. You can find vitamin K2 in foods that come from animals and in the cans. The vitamin K2 market is seeing growth due to factors such the rising occurrence of cardiovascular disease and osteoporosis in both adults and babies. Conversely, the market expansion is impeded by the lack of understanding regarding the benefits of vitamin K2.
Over the forecast period, the market growth could be affected by the growing prevalence of COVID-19. The healthcare business has been profoundly and immediately affected by the COVID-19 challenge. Most nutraceutical and pharmaceutical companies had a little loss in the first three quarters due to the unexpected effects on the supply chain and the limitations placed on production and supply operations during the early phases of the coronavirus pandemic. However, several key players have witnessed positive sales growth as a consequence of the increased demand for nutraceuticals, particularly Vitamin K2, which has been driven up by COVID-19.
Cases of vitamin insufficiency have been rising at a steady rate over the past few years. Nutraceuticals containing vitamins are in high demand due to the rise in vitamin-deficient disorders. Another problem is the lack of vitamin K2. Babies suffering with Vitamin K2 Deficiency Bleeding (VKDB) are unable to control their bleeding because their blood does not have enough Vitamin K2 to form clots. Significant clinical data supports the significance of vitamins for general well-being and their benefits for the human body, particularly the bones. In the United States, 44 million people have inadequate bone density in 2021, with approximately 10 million suffering from osteoporosis. Nutritional supplements, food fortification, pharmaceutical-grade injections, and oral supplements containing vitamin K will see an uptick in sales as a result of this aspect.
An increase in aesthetic standards and the prevalence of osteoporosis are two major factors propelling the vitamin K2 market. Osteoporosis hinders how the human body grows new tissues. Medication containing vitamin K2 will so remain in great demand. More than 38 million individuals across the globe are affected by osteoporosis, according to data from the 2019–20 Osteoporosis Foundation.
With a frequency that has been rising over the past few years, cardiovascular disease (CVD) remains a major problem for world health. The prevalence of risk factors such as diabetes, hypercholesterolemia, and hypertension, as well as an aging population, sedentary lifestyles, and unhealthy eating habits, all contributing to this increase. Globally, around 17.9 million people lose their lives each year due to cardiovascular disease (CVD), as reported by the World Health Organization. Additionally, in 2023, cardiovascular disease (CVD) accounted for 37% of all fatalities in the European Union, with over 1.7 million people losing their lives to the disease. This puts it among the top causes of death in the region, according to the European Environment Agency.
Report Coverage
Global Vitamin K2 research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Vitamin K2 report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Vitamin K2 competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Vitamin K2 market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Vitamin K2 market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Vitamin K2 market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Kappa Bioscience, NattoPharma, GNOSIS S.p.A., Viridis BioPharma, Seebio Biotech, DSM, DuPont, Geneferm Biotechnology Co. Ltd., International Flavors & Fragrances, Inc., and KYOWA HAKKO BIO CO., LTD.
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Vitamin K2 market based on the below-mentioned segments:
Global Vitamin K2 Market, By Product Type
MK-7
MK-4 & Combination Drugs
Global Vitamin K2 market, By Application
Nutraceutical
Food & Pharmaceutical
Global Vitamin K2 Market, By Form
Capsules & Tablets
Powder
Oil
Global Vitamin K2 market, Regional Analysis
Blood clotting, heart health, and bone density are among areas that vitamin K2 can influence. Among them, MK-4 and MK-7 stand out. A reduced risk of heart disease is closely linked to a higher intake of vitamin K2. In addition to preventing heart disease and promoting healthy brain function, it also aids in skin health and bone metabolism. Vitamin K2 also aids in calcium use, which is critical for bone growth and vascular calcification prevention. By activating the matrix GLA protein (MGP), vitamin K2 inhibits the calcification of blood arteries, protecting them from harm.
Since un-carboxylated or inactive MGP causes cardiovascular disease, vitamin K2 deficiency is a direct cause of this condition. Vitamin K2 also helps the blood clot. To avoid internal and external bleeding, vitamin K2 is necessary for the synthesis of several proteins that are involved in blood clotting. You can find vitamin K2 in foods that come from animals and in the cans. The vitamin K2 market is seeing growth due to factors such the rising occurrence of cardiovascular disease and osteoporosis in both adults and babies. Conversely, the market expansion is impeded by the lack of understanding regarding the benefits of vitamin K2.
Over the forecast period, the market growth could be affected by the growing prevalence of COVID-19. The healthcare business has been profoundly and immediately affected by the COVID-19 challenge. Most nutraceutical and pharmaceutical companies had a little loss in the first three quarters due to the unexpected effects on the supply chain and the limitations placed on production and supply operations during the early phases of the coronavirus pandemic. However, several key players have witnessed positive sales growth as a consequence of the increased demand for nutraceuticals, particularly Vitamin K2, which has been driven up by COVID-19.
Cases of vitamin insufficiency have been rising at a steady rate over the past few years. Nutraceuticals containing vitamins are in high demand due to the rise in vitamin-deficient disorders. Another problem is the lack of vitamin K2. Babies suffering with Vitamin K2 Deficiency Bleeding (VKDB) are unable to control their bleeding because their blood does not have enough Vitamin K2 to form clots. Significant clinical data supports the significance of vitamins for general well-being and their benefits for the human body, particularly the bones. In the United States, 44 million people have inadequate bone density in 2021, with approximately 10 million suffering from osteoporosis. Nutritional supplements, food fortification, pharmaceutical-grade injections, and oral supplements containing vitamin K will see an uptick in sales as a result of this aspect.
An increase in aesthetic standards and the prevalence of osteoporosis are two major factors propelling the vitamin K2 market. Osteoporosis hinders how the human body grows new tissues. Medication containing vitamin K2 will so remain in great demand. More than 38 million individuals across the globe are affected by osteoporosis, according to data from the 2019–20 Osteoporosis Foundation.
With a frequency that has been rising over the past few years, cardiovascular disease (CVD) remains a major problem for world health. The prevalence of risk factors such as diabetes, hypercholesterolemia, and hypertension, as well as an aging population, sedentary lifestyles, and unhealthy eating habits, all contributing to this increase. Globally, around 17.9 million people lose their lives each year due to cardiovascular disease (CVD), as reported by the World Health Organization. Additionally, in 2023, cardiovascular disease (CVD) accounted for 37% of all fatalities in the European Union, with over 1.7 million people losing their lives to the disease. This puts it among the top causes of death in the region, according to the European Environment Agency.
Report Coverage
Global Vitamin K2 research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Vitamin K2 report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Vitamin K2 competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Vitamin K2 market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2031 |
| Base Year | 2024 |
| Forecast Period | 2024-2031 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Kappa Bioscience, NattoPharma, GNOSIS S.p.A., Viridis BioPharma, Seebio Biotech, DSM, DuPont, Geneferm Biotechnology Co. Ltd., International Flavors & Fragrances, Inc., and KYOWA HAKKO BIO CO., LTD. |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Vitamin K2 Market from 2021 to 2031.
- Market Forecast for Vitamin K2 Market from 2021 to 2031.
- Regional Market Share and Revenue from 2021 to 2031.
- Country Market share within region from 2021 to 2031.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Vitamin K2 competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Vitamin K2
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Vitamin K2 market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Vitamin K2 market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Kappa Bioscience, NattoPharma, GNOSIS S.p.A., Viridis BioPharma, Seebio Biotech, DSM, DuPont, Geneferm Biotechnology Co. Ltd., International Flavors & Fragrances, Inc., and KYOWA HAKKO BIO CO., LTD.
Primary Target Market
- Market Players of Vitamin K2
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Vitamin K2 market based on the below-mentioned segments:
Global Vitamin K2 Market, By Product Type
MK-7
MK-4 & Combination Drugs
Global Vitamin K2 market, By Application
Nutraceutical
Food & Pharmaceutical
Global Vitamin K2 Market, By Form
Capsules & Tablets
Powder
Oil
Global Vitamin K2 market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive vitamin k2 market market research and competitor analysis for your business to help you develop more profound insights into the vitamin k2 market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the vitamin k2 market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.